Division of Cardiac Surgery, St Michael's Hospital of Unity Health Toronto, Toronto, Ontario, Canada; Keenan Research Centre for Biomedical Science and Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.
Division of Cardiac Surgery, St Michael's Hospital of Unity Health Toronto, Toronto, Ontario, Canada; Keenan Research Centre for Biomedical Science and Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Ontario, Canada; Division of Endocrinology and Metabolism, St Michael's Hospital of Unity Health Toronto, Toronto, Ontario, Canada.
J Am Coll Cardiol. 2024 Feb 20;83(7):755-769. doi: 10.1016/j.jacc.2023.12.012.
South Asian individuals shoulder a disproportionate burden of cardiometabolic diseases.
The purpose of this study was to determine if vascular regenerative cell content varies significantly between South Asian and White European people.
Between January 2022 and January 2023, 60 South Asian and 60 White European adults with either documented cardiovascular disease or established diabetes with ≥1 other cardiovascular risk factor were prospectively enrolled. Vascular regenerative cell content in venous blood was enumerated using a flow cytometry assay that is based on high aldehyde dehydrogenase (ALDH) activity and cell surface marker phenotyping. The primary outcome was the difference in frequency of circulating ALDH progenitor cells, monocytes, and granulocytes between the 2 groups.
Compared with White European participants, those of South Asian ethnicity were younger (69 ± 10 years vs 66 ± 9 years; P < 0.05), had lower weight (88 ± 19 kg vs 75 ± 13 kg; P < 0.001), and exhibited a greater prevalence of type 2 diabetes (62% vs 92%). South Asian individuals had markedly lower circulating frequencies of pro-angiogenic ALDHSSCCD133 progenitor cells (P < 0.001) and ALDHSSCCD14CD163 monocytes with vessel-reparative capacity (P < 0.001), as well as proportionally more ALDH progenitor cells with high reactive oxygen species content (P < 0.05). After correction for sex, age, body mass index, and glycated hemoglobin, South Asian ethnicity was independently associated with lower ALDHSSCCD133 cell count.
South Asian people with cardiometabolic disease had less vascular regenerative and reparative cells suggesting compromised vessel repair capabilities that may contribute to the excess vascular risk in this population. (The Role of South Asian vs European Origins on Circulating Regenerative Cell Exhaustion [ORIGINS-RCE]; NCT05253521).
南亚个体在代谢相关心血管疾病方面承受着不成比例的负担。
本研究旨在确定南亚人和白种欧洲人之间血管再生细胞含量是否存在显著差异。
在 2022 年 1 月至 2023 年 1 月期间,前瞻性纳入了 60 名南亚人和 60 名白种欧洲成年人,这些人要么患有已确诊的心血管疾病,要么患有 1 种以上心血管风险因素的已确诊糖尿病。使用基于高醛脱氢酶(ALDH)活性和细胞表面标志物表型的流式细胞术检测,对静脉血中血管再生细胞含量进行计数。主要结局是两组间循环 ALDH 祖细胞、单核细胞和粒细胞的频率差异。
与白种欧洲参与者相比,南亚裔参与者年龄更小(69±10 岁比 66±9 岁;P<0.05)、体重更轻(88±19 千克比 75±13 千克;P<0.001),并且 2 型糖尿病的患病率更高(62%比 92%)。南亚个体的促血管生成 ALDHSSCCD133 祖细胞(P<0.001)和具有血管修复能力的 ALDHSSCCD14CD163 单核细胞的循环频率明显较低,以及具有高活性氧含量的 ALDH 祖细胞比例较高(P<0.05)。在校正性别、年龄、体重指数和糖化血红蛋白后,南亚种族与较低的 ALDHSSCCD133 细胞计数独立相关。
患有代谢相关心血管疾病的南亚人血管再生和修复细胞较少,表明血管修复能力受损,这可能导致该人群的血管风险增加。(起源于南亚与欧洲对循环再生细胞耗竭的影响[ORIGINS-RCE];NCT05253521)。